Download Diagnostic Imaging: Nuclear Medicine, PDF

Download Diagnostic Imaging: Nuclear Medicine, PDF
by Kathryn A. Morton MD (Author), Paige B. Clark MD (Author), Carl R. Christensen MD (Author), Janis P. O’Malley MD (Author), Todd M. Blodgett MD (Author), Alan Waxman MD (Author), Jeffrey S. Stevens MD (Author), & 5 more

Authored by some of the world’s preeminent authorities in its field, this new book represents today’s best single source of guidance on nuclear imaging! It offers more details for each diagnosis · more representative images · more case data · and more current references than any other reference tool. At the same time, its user-friendly format lets you access all of this information remarkably quickly!
Covers the top imaging diagnoses in nuclear medicine, including both common and uncommon entities.
Provides exquisitely reproduced imaging examples for every diagnosis―plus concise, bulleted summaries of terminology · imaging findings · key facts · differential diagnosis · pathology · clinical issues · a diagnostic checklist · and selected references.
Includes an extensive image gallery for each entity, depicting common and variant cases.
Offers a vivid, full-color design that makes the material easy to read.
Displays a “thumbnail” visual differential diagnosis for each entity.

diagnostic-imaging-nuclear-medicine

Table of Contents
Diagnostic Imaging Nuclear………………………………………………………………………………………………………….. 7
Cover ……………………………………………………………………………………………………………………………………. 7
Authors…………………………………………………………………………………………………………………………………. 7
Dedication …………………………………………………………………………………………………………………………….. 8
Foreword ………………………………………………………………………………………………………………………………. 9
Preface …………………………………………………………………………………………………………………………………. 9
Acknowledgments ………………………………………………………………………………………………………………….10
Introduction ………………………………………………………………………………………………………………………….10
Section 1 – Musculoskeletal………………………………………………………………………………………………………11
I. Benign Bone Tumors …………………………………………………………………………………………………………11
Osteoid Osteoma …………………………………………………………………………………………………………….11
Enchondroma …………………………………………………………………………………………………………………18
Fibrous Cortical Defect ……………………………………………………………………………………………………..22
Bone Cyst, Aneurysmal……………………………………………………………………………………………………..26
Bone Cyst, Solitary …………………………………………………………………………………………………………..30
Giant Cell Tumor ……………………………………………………………………………………………………………..37
II. Malignant Bone Tumors ……………………………………………………………………………………………………41
Skeletal Metastases …………………………………………………………………………………………………………41
Superscan ………………………………………………………………………………………………………………………51
Osteosarcoma …………………………………………………………………………………………………………………58
Ewing Sarcoma ………………………………………………………………………………………………………………..68
Chondrosarcoma ……………………………………………………………………………………………………………..75
Prostate Cancer, Bone Metastases ……………………………………………………………………………………..82
III. Therapy …………………………………………………………………………………………………………………………86
Palliation of Metastatic Bone Pain ………………………………………………………………………………………86
IV. Infection ……………………………………………………………………………………………………………………….93
Cellulitis …………………………………………………………………………………………………………………………93
Osteomyelitis, Appendicular ……………………………………………………………………………………………100
Osteomyelitis, Axial ………………………………………………………………………………………………………..110
Osteomyelitis, Temporal Bone …………………………………………………………………………………………114
Osteomyelitis, Feet ………………………………………………………………………………………………………..118
Osteomyelitis, Pediatric ………………………………………………………………………………………………….125
V. Metabolic Bone Disease ………………………………………………………………………………………………….135
Hyperparathyroidism ……………………………………………………………………………………………………..135
Osteomalacia ………………………………………………………………………………………………………………..142
Hypertrophic Osteoarthropathy ……………………………………………………………………………………….149
VI. Dysplasias ……………………………………………………………………………………………………………………159
Paget Disease ………………………………………………………………………………………………………………..159
Fibrous Dysplasia …………………………………………………………………………………………………………..166
Melorheostosis ……………………………………………………………………………………………………………..170
Multiple Enchondromatoses ……………………………………………………………………………………………177
Multiple Hereditary Exostoses ………………………………………………………………………………………….184
VII. Avascular Necrosis ……………………………………………………………………………………………………….191
Osseous Necrosis …………………………………………………………………………………………………………..191
Legg-Calve Perthes Disease ……………………………………………………………………………………………..198
VIII. Surgical Assessment …………………………………………………………………………………………………….202
Joint Prostheses, Painful………………………………………………………………………………………………….202
Failed Back Surgery Syndrome …………………………………………………………………………………………206
IX. Skeletal Trauma ……………………………………………………………………………………………………………216
Insufficiency Fracture ……………………………………………………………………………………………………..216
Fracture ……………………………………………………………………………………………………………………….226
Diagnostic Imaging Nuclear
2
Trauma, Non-Accidental ………………………………………………………………………………………………….230
Stress Fracture ………………………………………………………………………………………………………………234
X. Regional Pain Evaluation …………………………………………………………………………………………………241
Arthritis, Non-Infectious ………………………………………………………………………………………………….241
Complex Regional Pain Syndrome …………………………………………………………………………………….248
Hip Pain ……………………………………………………………………………………………………………………….255
Wrist Pain …………………………………………………………………………………………………………………….262
Calcaneal Pain ……………………………………………………………………………………………………………….272
Knee Pain ……………………………………………………………………………………………………………………..279
XI. Skeletal Muscle & Soft Tissues…………………………………………………………………………………………286
Heterotopic Ossification ………………………………………………………………………………………………….286
Skeletal Muscle Disorders ……………………………………………………………………………………………….296
Amyloidosis…………………………………………………………………………………………………………………..303
XII. Bone Marrow Disorders ………………………………………………………………………………………………..307
Hematoproliferative Disorders …………………………………………………………………………………………307
Sickle Cell Disease, Bone Pain …………………………………………………………………………………………..317
Multiple Myeloma ………………………………………………………………………………………………………….324
Section 2 – Vascular and Lymphatics…………………………………………………………………………………………331
I. Lymphatic ……………………………………………………………………………………………………………………..331
Lymphedema ………………………………………………………………………………………………………………..331
Sentinel Lymph Node Mapping ………………………………………………………………………………………..335
II. Vascular ……………………………………………………………………………………………………………………….342
Large Vessel Vasculitis …………………………………………………………………………………………………….342
Atherosclerosis ……………………………………………………………………………………………………………..346
Vascular Thrombosis ………………………………………………………………………………………………………353
Vascular Graft Infection ………………………………………………………………………………………………….357
Section 3 – Cardiovascular ………………………………………………………………………………………………………367
I. Introduction and Overview……………………………………………………………………………………………….367
Cardiovascular Overview …………………………………………………………………………………………………367
II. Cardiac …………………………………………………………………………………………………………………………375
Cardiomyopathy ……………………………………………………………………………………………………………375
Valvular Heart Disease ……………………………………………………………………………………………………385
Myocardial Ischemia ………………………………………………………………………………………………………392
Myocardial Viability ……………………………………………………………………………………………………….402
Myocardial Infarction ……………………………………………………………………………………………………..409
Cardiac Transplant …………………………………………………………………………………………………………419
Left-to-Right Intracardiac Shunts ………………………………………………………………………………………426
Right-to-Left Intracardiac Shunts ………………………………………………………………………………………430
Section 4 – Chest and Mediastinum ………………………………………………………………………………………….434
I. Introduction and Overview……………………………………………………………………………………………….434
VQ Scan Overview ………………………………………………………………………………………………………….434
II. Lung Ventillation & Perfusion Abnormalities ………………………………………………………………………443
VQ, Pulmonary Embolism ………………………………………………………………………………………………..443
VQ, Quantitative ……………………………………………………………………………………………………………450
III. Lung Infection & Inflammation ………………………………………………………………………………………..460
Pneumocystis Carinii Pneumonia………………………………………………………………………………………460
Interstitial Lung Disease ………………………………………………………………………………………………….467
Granulomatous Disease ………………………………………………………………………………………………….474
IV. Lung Cancer …………………………………………………………………………………………………………………481
Solitary Pulmonary Nodule ………………………………………………………………………………………………481
Non-Small Cell Lung Cancer ……………………………………………………………………………………………..488
Metastases, Lungs and Mediastinum…………………………………………………………………………………498
V. Pleura ………………………………………………………………………………………………………………………….505
Pleural Disease, Malignant and Inflammatory …………………………………………………………………….505
Diagnostic Imaging Nuclear
3
VI. Mediastinum ……………………………………………………………………………………………………………….512
Thymic Evaluation ………………………………………………………………………………………………………….512
Pericardial Disease, Malignant and Inflammatory ………………………………………………………………..519
Section 5 – CNS …………………………………………………………………………………………………………………….526
I. Introduction and Overview……………………………………………………………………………………………….526
Brain Imaging Overview ………………………………………………………………………………………………….526
II. Vascular Assessment ………………………………………………………………………………………………………531
Brain Death …………………………………………………………………………………………………………………..531
Cerebral Vascular Occlusion …………………………………………………………………………………………….541
Blood Brain Barrier Disruption ………………………………………………………………………………………….548
III. Seizure Assessment ……………………………………………………………………………………………………….552
Seizure Evaluation ………………………………………………………………………………………………………….552
IV. Dementia & Neurodegenerative ……………………………………………………………………………………..562
Alzheimer Disease ………………………………………………………………………………………………………….562
Dementia and Neurodegenerative, Other ………………………………………………………………………….569
V. Neurooncology ……………………………………………………………………………………………………………..579
Gliomas and Astrocytomas ………………………………………………………………………………………………579
Primary CNS Lymphoma ………………………………………………………………………………………………….586
Metastases, Brain…………………………………………………………………………………………………………..593
Radiation Necrosis vs Recurrent Tumor ……………………………………………………………………………..600
VI. CSF Imaging …………………………………………………………………………………………………………………610
CSF Leak ……………………………………………………………………………………………………………………….610
Ventricular Shunt Dysfunction ………………………………………………………………………………………….617
Normal Pressure Hydrocephalus ………………………………………………………………………………………624
VII. Miscellaneous ……………………………………………………………………………………………………………..634
Heterotopic Gray Matter …………………………………………………………………………………………………634
Brain Infection and Inflammation ……………………………………………………………………………………..644
Psychiatry, Drug Addiction and Forensics …………………………………………………………………………..651
Section 6 – Head and Neck ……………………………………………………………………………………………………..661
I. Squamous Cell Carcinoma of the Head and Neck ………………………………………………………………….661
SCCHN, Staging ……………………………………………………………………………………………………………..661
SCCHN, Primary Unknown ……………………………………………………………………………………………….668
SCCHN, Therapeutic Assessment – Restaging ………………………………………………………………………672
II. Miscellaneous Primary Head and Neck Tumors …………………………………………………………………..679
Parotid and Salivary Tumors …………………………………………………………………………………………….679
Neuroendocrine Tumors, Head and Neck …………………………………………………………………………..683
III. Miscellaneous ………………………………………………………………………………………………………………690
Lacrimal Complex Dysfunction …………………………………………………………………………………………690
Section 7 – Thyroid & Parathyroid ……………………………………………………………………………………………694
I. Introduction and Overview……………………………………………………………………………………………….694
Thyroid Overview …………………………………………………………………………………………………………..694
II. Parathyroid …………………………………………………………………………………………………………………..702
Parathyroid Adenoma, Typical………………………………………………………………………………………….702
Parathyroid Adenoma, Ectopic …………………………………………………………………………………………710
III. Hyperthyroidism …………………………………………………………………………………………………………..714
Graves Disease ………………………………………………………………………………………………………………714
Hashimoto Thyroiditis …………………………………………………………………………………………………….721
Multinodular Goiter ……………………………………………………………………………………………………….728
Thyroid Adenoma, Hyperfunctioning …………………………………………………………………………………735
Subacute Thyroiditis ……………………………………………………………………………………………………….742
I-131 Hyperthyroid Therapy …………………………………………………………………………………………….749
IV. Thyroid, Benign Miscellaneous ………………………………………………………………………………………..756
Ectopic Thyroid ……………………………………………………………………………………………………………..756
Congenital Hypothyroidism ……………………………………………………………………………………………..763
Diagnostic Imaging Nuclear
4
Benign Thyroid Conditions, PET ………………………………………………………………………………………..770
V. Thyroid Cancer ………………………………………………………………………………………………………………777
Well-Differentiated Thyroid Cancer …………………………………………………………………………………..777
I-131 Thyroid Cancer Therapy ………………………………………………………………………………………….787
Well-Differentiated Thyroid Cancer, PET ……………………………………………………………………………794
Medullary Thyroid Cancer ……………………………………………………………………………………………….801
Section 8 – Gastrointestinal …………………………………………………………………………………………………….808
I. Introduction and Overview……………………………………………………………………………………………….808
GI Anatomy and Imaging Issues ………………………………………………………………………………………..808
II. Biliary …………………………………………………………………………………………………………………………..812
Acute Calculous Cholecystitis …………………………………………………………………………………………..812
Acute Acalculous Cholecystitis …………………………………………………………………………………………822
Chronic Cholecystitis ………………………………………………………………………………………………………832
Biliary Leak ……………………………………………………………………………………………………………………839
Common Bile Duct Obstruction ………………………………………………………………………………………..843
Choledochal Cyst ……………………………………………………………………………………………………………847
Biliary Bypass Obstruction ……………………………………………………………………………………………….854
Biliary Atresia ………………………………………………………………………………………………………………..858
Cholangiocarcinoma ……………………………………………………………………………………………………….865
Gallbladder Cancer …………………………………………………………………………………………………………872
III. Hepatic ……………………………………………………………………………………………………………………….879
Focal Nodular Hyperplasia ……………………………………………………………………………………………….879
Hepatic Cirrhosis ……………………………………………………………………………………………………………886
Hypersplenism ………………………………………………………………………………………………………………896
Hepatic Metastases ………………………………………………………………………………………………………..903
Hepatoblastoma ……………………………………………………………………………………………………………910
Hepatocellular Carcinoma ……………………………………………………………………………………………….917
Cavernous Hemangiomas ………………………………………………………………………………………………..927
IV. Adrenal ……………………………………………………………………………………………………………………….934
Adrenal Malignancy ……………………………………………………………………………………………………….934
Pheochromocytoma ……………………………………………………………………………………………………….944
Neuroblastoma ……………………………………………………………………………………………………………..951
V. Spleen ………………………………………………………………………………………………………………………….961
Asplenia-Polysplenia Syndromes ………………………………………………………………………………………961
Accessory and Ectopic Splenic Tissue…………………………………………………………………………………968
VI. Oropharynx & Esophagus ……………………………………………………………………………………………….975
Esophageal Cancer …………………………………………………………………………………………………………975
Esophageal Dysmotility …………………………………………………………………………………………………..982
VII. Stomach……………………………………………………………………………………………………………………..989
Gastritis ……………………………………………………………………………………………………………………….989
Gastric Emptying Disorders ……………………………………………………………………………………………..993
Gastric Carcinoma ……………………………………………………………………………………………………….. 1000
VIII. Intestine …………………………………………………………………………………………………………………. 1007
Intestinal Cancer, Primary and Staging ……………………………………………………………………………. 1007
Intestinal Cancer, Therapy Eval – Restaging………………………………………………………………………. 1014
Meckel Diverticulum ……………………………………………………………………………………………………. 1018
GI Bleeding Localization ……………………………………………………………………………………………….. 1025
Inflammatory Bowel Disease …………………………………………………………………………………………. 1032
IX. Pancreas …………………………………………………………………………………………………………………… 1039
Pancreatitis ………………………………………………………………………………………………………………… 1039
Pancreatic Adenocarcinoma ………………………………………………………………………………………….. 1043
Islet Cell Tumors………………………………………………………………………………………………………….. 1050
X. Miscellaneous …………………………………………………………………………………………………………….. 1057
Intraabdominal Infection ………………………………………………………………………………………………. 1057
Diagnostic Imaging Nuclear
5
Carcinoid Tumor …………………………………………………………………………………………………………. 1067
GI Stromal Tumors ………………………………………………………………………………………………………. 1074
Peritoneal Systemic Shunt Evaluation……………………………………………………………………………… 1081
Diaphragmatic Patency Determination ……………………………………………………………………………. 1088
Intraarterial Hepatic Pump Evaluation …………………………………………………………………………….. 1092
Section 9 – Genitourinary …………………………………………………………………………………………………….. 1096
I. Kidney ………………………………………………………………………………………………………………………… 1096
Renal Cortical Scar ………………………………………………………………………………………………………. 1096
Renal Ectopy ………………………………………………………………………………………………………………. 1103
Renovascular Hypertension …………………………………………………………………………………………… 1110
Acute Renal Failure ……………………………………………………………………………………………………… 1117
Renal Masses ……………………………………………………………………………………………………………… 1127
Renal Cell Carcinoma……………………………………………………………………………………………………. 1131
Pyelonephritis …………………………………………………………………………………………………………….. 1138
Renal Transplant …………………………………………………………………………………………………………. 1145
Renal Function Quantification ……………………………………………………………………………………….. 1155
II. Collecting System ………………………………………………………………………………………………………… 1162
Obstructive Uropathy …………………………………………………………………………………………………… 1162
Reflux Uropathy ………………………………………………………………………………………………………….. 1169
Urinary Bladder and Epithelial Cancer …………………………………………………………………………….. 1176
III. Testes ………………………………………………………………………………………………………………………. 1183
Testicular Torsion ………………………………………………………………………………………………………… 1183
Testicular Cancer…………………………………………………………………………………………………………. 1190
IV. Ovaries …………………………………………………………………………………………………………………….. 1197
Ovaries, Normal and Benign Pathology……………………………………………………………………………. 1197
Ovarian Cancer……………………………………………………………………………………………………………. 1201
V. Uterus ……………………………………………………………………………………………………………………….. 1208
Uterus, Normal and Benign Pathology …………………………………………………………………………….. 1208
Cervical Cancer …………………………………………………………………………………………………………… 1212
Endometrial Cancer ……………………………………………………………………………………………………… 1219
VI. Prostate ……………………………………………………………………………………………………………………. 1226
Prostate Cancer, Antibody Scan……………………………………………………………………………………… 1226
Section 10 – HemeOnc Procedures & Therapies ………………………………………………………………………. 1230
I. Therapy – Oncology ………………………………………………………………………………………………………. 1230
Phosphorus-32 Therapies ……………………………………………………………………………………………… 1230
Hepatic Arterial Y-90 Microspheres ………………………………………………………………………………… 1234
Radiolabeled Antibody Therapy …………………………………………………………………………………….. 1241
II. Hematologic Procedures ………………………………………………………………………………………………. 1248
RBC Survival and Splenic Sequestration …………………………………………………………………………… 1248
Red Cell Mass and Plasma Volume …………………………………………………………………………………. 1252
Schilling Test ………………………………………………………………………………………………………………. 1256
Section 11 – Oncology, Other ……………………………………………………………………………………………….. 1260
I. Lymphoma ………………………………………………………………………………………………………………….. 1260
Lymphoma, Benign Mimics …………………………………………………………………………………………… 1260
Hodgkin Lymphoma Staging ………………………………………………………………………………………….. 1267
Lymphoma Post-Therapy Evaluation ………………………………………………………………………………. 1274
Non-Hodgkin Lymphomas, Low Grade …………………………………………………………………………….. 1284
Non-Hodgkin Lymphoma Staging …………………………………………………………………………………… 1291
II. Melanoma………………………………………………………………………………………………………………….. 1298
Melanoma Staging ………………………………………………………………………………………………………. 1298
Melanoma Therapy Evaluation – Restaging ………………………………………………………………………. 1305
III. Breast Cancer …………………………………………………………………………………………………………….. 1312
Breast, Benign Disease …………………………………………………………………………………………………. 1312
Breast Cancer, Primary …………………………………………………………………………………………………. 1316
Diagnostic Imaging Nuclear
6
Breast Cancer, Staging – Restaging ………………………………………………………………………………….. 1326
IV. Miscellaneous ……………………………………………………………………………………………………………. 1336
Adenocarcinoma of Unknown Primary ……………………………………………………………………………. 1336
Paraneoplastic Disorders ………………………………………………………………………………………………. 1340
Index ……………………………………………………………………………………………………………………………….. 1348
A ………………………………………………………………………………………………………………………………….. 13499

Download Diagnostic Imaging: Nuclear Medicine, PDF

List Price: $134.46 USD
New From: $111.99 USD
Download Ebook pdf Get it $20 USD
Payments secured by Paypal
Refund when you don't received ebook
Send fastest ebook in 24 hours
Customer requirements document sent to mail: Ducvatgia68@gmail.com
Payment
Your Email Address:

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *